ICD-10 Coding for Facial Lesion(C44.01, C44.11, C44.30)
Explore detailed ICD-10 coding guidelines for facial lesions, including basal cell carcinoma and seborrheic keratosis. Learn about documentation requirements and billing considerations.
Complete code families applicable to Facial Lesion
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C44.31 | Basal cell carcinoma of skin of other parts of face | Use when a biopsy confirms basal cell carcinoma on the face, excluding eyelids and lips. |
|
| L82.0 | Inflamed seborrheic keratosis | Use when seborrheic keratosis is inflamed and located on the face. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutFacial Lesion
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Facial Lesion.
Omitting lesion size in documentation
Impact
Clinical: May affect treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims due to insufficient documentation.
Mitigation
Include lesion size in all clinical notes., Use templates to ensure completeness.
Using C44.32 for unspecified facial location
Impact
Reimbursement: May lead to reduced reimbursement due to lack of specificity., Compliance: Non-compliance with coding guidelines requiring specificity., Data Quality: Decreases data accuracy for clinical and research purposes.
Mitigation
Specify the exact location on the face to use a more specific code.
Unspecified lesion location
Impact
Coding without specifying the exact facial location increases audit risk.
Mitigation
Train staff to document precise anatomical locations in clinical notes.